Biotech Values

[jbog]

Dew,,,,,

A simple question, we know that mircera is blocked from the u.s. markets because of Amgens patents and amgen will have control of the market by itself. We also know that amgen is running into safety problems etc. with these products. What would happen if we found out that cera did not have these common problems just like the similar to the vioxx and celebrex story. The patents in question are more in the manufacturing phase than the patient stage.

Could Amgen be forced to allow cera come to market and be paid a percentage?